Literature DB >> 23929343

Public biotech 2012--the numbers.

Brady Huggett1.   

Abstract

Mesh：

Year:  2013        PMID： 23929343     DOI： 10.1038/nbt.2653

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  7 in total

1.  Raising financing through strategic timing.

Authors:  Elicia Maine; V J Thomas
Journal:  Nat Nanotechnol       Date:  2017-02-07       Impact factor: 39.213

2.  Fourth-quarter biotech job picture.

Authors:  Michael Francisco
Journal:  Nat Biotechnol       Date:  2014-02       Impact factor: 54.908

3.  First-quarter biotech job picture.

Authors:  Michael Francisco
Journal:  Nat Biotechnol       Date:  2014-05       Impact factor: 54.908

4.  Bringing up baby.

Authors:  Brady Huggett
Journal:  Nat Biotechnol       Date:  2018-05-09       Impact factor: 54.908

Review 5.  [Rheumatoid arthritis].

Authors:  D Aletaha; A Kerschbaumer
Journal:  Z Rheumatol       Date:  2017-02       Impact factor: 1.372

Review 6.  Better and faster: improvements and optimization for mammalian recombinant protein production.

Authors:  Steven C Almo; James D Love
Journal:  Curr Opin Struct Biol       Date:  2014-04-12       Impact factor: 6.809

7.  Disease activity guided dose reduction and withdrawal of adalimumab or etanercept compared with usual care in rheumatoid arthritis: open label, randomised controlled, non-inferiority trial.

Authors:  Noortje van Herwaarden; Aatke van der Maas; Michiel J M Minten; Frank H J van den Hoogen; Wietske Kievit; Ronald F van Vollenhoven; Johannes W J Bijlsma; Bart J F van den Bemt; Alfons A den Broeder
Journal:  BMJ       Date:  2015-04-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.